Perivaccination Antimetabolite Hold and Third Dose of SARS-CoV-2 Vaccine in Lung Transplant Recipients: Preliminary Report.
作者信息
Frey Sarah, Ruck Jessica M, Alejo Jennifer L, Barker Lindsay, Matthew Joby, Werbel William A, Avery Robin K, Segev Dorry L, Shah Pali D
机构信息
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Division of Pulmonology and Critical Care, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
出版信息
Transplantation. 2022 Sep 1;106(9):e426-e428. doi: 10.1097/TP.0000000000004240. Epub 2022 Jun 14.
Abstract
摘要
相似文献
1
Perivaccination Antimetabolite Hold and Third Dose of SARS-CoV-2 Vaccine in Lung Transplant Recipients: Preliminary Report.肺移植受者接种疫苗期间使用抗代谢物并延迟接种第三剂严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗：初步报告
Transplantation. 2022 Sep 1;106(9):e426-e428. doi: 10.1097/TP.0000000000004240. Epub 2022 Jun 14.
2
Effect of antimetabolite regimen on cellular and humoral immune response to SARS-COV-2 vaccination in solid organ transplant recipients.抗代谢药物方案对实体器官移植受者接种 SARS-CoV-2 疫苗后细胞和体液免疫应答的影响。
Immunol Lett. 2024 Aug;268:106886. doi: 10.1016/j.imlet.2024.106886. Epub 2024 Jun 19.
3
Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination-specific humoral and cellular immunity in kidney transplant recipients.临时抗代谢药物治疗暂停可增强肾移植受者中针对 SARS-CoV-2 疫苗的体液和细胞免疫。
JCI Insight. 2022 May 9;7(9):e157836. doi: 10.1172/jci.insight.157836.
4
SARS-CoV-2 vaccine antibody response and breakthrough infections in transplant recipients.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）疫苗在移植受者中的抗体反应及突破性感染
J Med Virol. 2023 Apr;95(4):e28736. doi: 10.1002/jmv.28736.
5
Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients.肺移植受者对第三剂基于mRNA的SARS-CoV-2疫苗的血清学反应。
Transpl Immunol. 2022 Jun;72:101599. doi: 10.1016/j.trim.2022.101599. Epub 2022 Apr 4.
6
Effect of Mycophenolate Mofetil Dosing on Antibody Response to SARS-CoV-2 Vaccination in Heart and Lung Transplant Recipients.霉酚酸酯剂量对心肺移植受者抗SARS-CoV-2疫苗抗体反应的影响。
Transplantation. 2022 May 1;106(5):e269-e270. doi: 10.1097/TP.0000000000004090. Epub 2022 Mar 3.
7
Serological findings following the second and third SARS-CoV-2 vaccines in lung transplant recipients.肺移植受者接种第二和第三剂 SARS-CoV-2 疫苗后的血清学发现。
Immun Inflamm Dis. 2022 Aug;10(8):e646. doi: 10.1002/iid3.646.
8
Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients.心脏和胸部移植受者对两剂 SARS-CoV-2 信使 RNA 疫苗 BNT162b2 的体液和 T 细胞应答较差。
Clin Res Cardiol. 2021 Aug;110(8):1142-1149. doi: 10.1007/s00392-021-01880-5. Epub 2021 Jul 9.
9
Immunologic response to SARS-CoV-2 mRNA vaccination in pediatric kidney transplant recipients.儿童肾移植受者对 SARS-CoV-2 mRNA 疫苗接种的免疫反应。
Pediatr Nephrol. 2023 Mar;38(3):859-866. doi: 10.1007/s00467-022-05679-y. Epub 2022 Jul 14.
10
Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.肾移植受者同源与异源第三剂疫苗接种后 4 周时的 SARS-CoV-2 抗体反应比较：一项随机临床试验。
JAMA Intern Med. 2022 Feb 1;182(2):165-171. doi: 10.1001/jamainternmed.2021.7372.
引用本文的文献
1
A Single-center Experience With >200 Lung Transplant Recipients With COVID-19 Infection.200 多名 COVID-19 感染肺移植受者的单中心经验
Transplant Direct. 2024 Aug 29;10(9):e1676. doi: 10.1097/TXD.0000000000001676. eCollection 2024 Sep.
2
Immune aging: biological mechanisms, clinical symptoms, and management in lung transplant recipients.免疫衰老：肺移植受者的生物学机制、临床症状及管理
Front Transplant. 2024 Feb 8;3:1356948. doi: 10.3389/frtra.2024.1356948. eCollection 2024.
3
Immunogenicity of a Third Dose of BNT162b2 Vaccine among Lung Transplant Recipients-A Prospective Cohort Study.肺移植受者中第三剂BNT162b2疫苗的免疫原性——一项前瞻性队列研究
Vaccines (Basel). 2023 Apr 4;11(4):799. doi: 10.3390/vaccines11040799.
4
[Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients.].[肾移植患者中严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）冠状病毒大流行（COVID-19）管理建议的更新。]
Nefrologia. 2022 Nov 15. doi: 10.1016/j.nefro.2022.11.001.
Zotero 插件